高级搜索

下调AnnexinA2的表达在促前列腺癌进展中的作用

丁 滔, 郑江花, 洪 斌, 邹依珩

丁 滔, 郑江花, 洪 斌, 邹依珩. 下调AnnexinA2的表达在促前列腺癌进展中的作用[J]. 肿瘤防治研究, 2014, 41(07): 745-750. DOI: 10.3971/j.issn.1000-8578.2014.07.013
引用本文: 丁 滔, 郑江花, 洪 斌, 邹依珩. 下调AnnexinA2的表达在促前列腺癌进展中的作用[J]. 肿瘤防治研究, 2014, 41(07): 745-750. DOI: 10.3971/j.issn.1000-8578.2014.07.013
DING Tao, ZHENG Jianghua, HONG Bin, ZOU Yiheng. Down-regulating AnnexinA2 Expression could Promote Invasion and Metastasis of Prostate Cancer[J]. Cancer Research on Prevention and Treatment, 2014, 41(07): 745-750. DOI: 10.3971/j.issn.1000-8578.2014.07.013
Citation: DING Tao, ZHENG Jianghua, HONG Bin, ZOU Yiheng. Down-regulating AnnexinA2 Expression could Promote Invasion and Metastasis of Prostate Cancer[J]. Cancer Research on Prevention and Treatment, 2014, 41(07): 745-750. DOI: 10.3971/j.issn.1000-8578.2014.07.013

下调AnnexinA2的表达在促前列腺癌进展中的作用

基金项目: 国家自然科学基金面上项目(81372318);上海市自然科学基金面上项目(13ZR1435000);上海市教委科研创新项目(13YZ049);上海市卫生局科研课题项目(20124309)
详细信息
    作者简介:

    丁滔(1970-),男,博士,副主任医师,主要从事泌尿系统肿瘤的研究

    通讯作者:

    郑江花,E-mail:jhzheng2013@sina.com

  • 中图分类号: R737.25

Down-regulating AnnexinA2 Expression could Promote Invasion and Metastasis of Prostate Cancer

  • 摘要: 目的 探讨AnnexinA2(ANXA2)的异常表达在前列腺癌(prostate cancer,PC)进展中的作用机制。方法 采用免疫组织化学化检测ANXA2在85例PC标本中的表达水平,Western blot检测不同转移潜能的前列腺癌细胞LNCaP、C4-2B 和PC-3、PC-3M中ANXA2的表达水平;siRNA技术干扰PC-3细胞中ANXA2表达后,MTT检测细胞增殖,Western blot检测MMP-2、MMP-9表达水平的改变,Transwell小室和划痕试验检测PC-3细胞体外侵袭能力及迁移能力的变化。结果 ANXA2阳性率在Gleason评分为5~6、7、8~10分中的阳性率分别是77.5%(31/40)、58.3%(21/36)、11.1%(1/9),三者之间表达差异有统计学意义(P <0.05),随着前列腺癌细胞转移潜能升高而ANXA2表达水平依次降低(P<0.01);siRNA技术干扰AnnexinA2表达后,PC-3-ANXA2-siRNA生长速度增加(P<0.05),Western blot检测到PC-3-ANXA2-siRNA细胞的ANXA2表达水平明显降低,而MMP-2、MMP-9表达水平上调,Transwell小室和划痕实验分别发现PC-3-ANXA2-siRNA细胞体外侵袭及迁移能力增加。结论 下调AnnexinA2的表达能够促进前列腺癌进展,机制上可能是通过上调MMP-2和MMP-9的表达来实现的。

     

    Abstract: Objective To analyze the mechanism of AnnexinA2 abnormal expression in invasion and metastasis of prostate cancer(PC). Methods A total of 85 PC specimens were paraffin-embedded and confirmed pathologically. AnnexinA2 expression in these specimens was determined by immunohistochemical staining. Western blot assay was conducted to detect AnnexinA2 expression in LNCaP and PC-3 with low metastasis potency, as well as and C4-2B and PC-3M with high metastasis potency. After siRNA was successfully performed in PC-3 cells to down-regulate AnnexinA2 expression, cell proliferation assay was performed by MTT method. Expression of MMP-2 and MMP-9 were detected by Western blot. Invasive abilities of PC-3 were detected by Transwell cabinet test in vitro. Migration abilities of PC-3 cells were detected by scratch test. Results The positive rates of AnnexinA2 expression were 77.5%(31/40), 58.3%(21/36), 11.1%(1/9) in the cases of Gleason scores 5~6, 7 and 8~10 in PC, respectively, with significant difference (P< 0.05). AnnexinA2 expression in C4-2B and PC-3M groups with high metastasis potency were lower than those in LNCaP and PC-3 groups with low metastasis potency (P<0.05). After siRNA was successfully performed in PC-3 cells to down-regulate AnnexinA2 expression, the growth speed in PC-3-ANXA2-siRNA cells was faster than those in PC-3, PC-3-Lip and PC-3-empty vector cells (P<0.05). AnnexinA2 expression in PC-3-ANXA2-siRNA cells was decreased while the expression of MMP-2 and MMP-9 were increased. Invasive ability of PC-3-ANXA2-siRNA cells detected by Transwell cabinet test was increased in vitro, and migrate abilities of PC-3-ANXA2-siRNA cells detected by scratch test was increased in vitro. Conclusion Down-regulating AnnexinA2 expression could promote invasion and metastasis of PC by up-regulating MMP-2 and MMP-9 expression.

     

  • [1] Ding Z, Wu CJ, Chu GC, et al. SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression[J]. Nature, 2011,470(7333): 269-73.
    [2] Ye DW,Li CL. Epidemiological trends of prostate cancer: retrospect and prospect[J]. Zhongguo Fei Ai Za Zhi,2007,17(3):177-80. [叶 定伟,李长岭. 前列腺癌发病趋势的回顾和展望[J]. 中国癌症杂 志,2007, 17(3):177-80.]
    [3] Mussunoor S, Murray GI. The role of annexins in tumour development and progression[J]. J Pathol, 2008, 216(2):131-40.
    [4] Bandorowicz-Piku?a J, Wo? M, Piku?a S. Participation of annexins in signal transduction, regulation of plasma membrane structure and membrane repair mechanisms[J]. Postepy Biochem,2012,58 (2) :135-48.
    [5] Bharadwaj A, Bydoun M, Holloway R, et al. Annexin A2 heterotetramer: structure and function[J]. Int J Mol Sci, 20 13,14(3): 6259-305.
    [6] Hiozawa Y, Havens AM, Jung Y, et al. Annexin II/annexin II receptor axis regulates adhesion, migration, homing, and growth of prostate cancer[J]. J Cell Biochem, 2008, 105(2):370-80.
    [7] Zhang J, Guo B, Zhang Y, et al. Silencing of the annexin II gene down-regulates the level of S100A10, c-Myc, and plasmin and inhibits breast cancer cell proliferation and invasion[J]. Saudi Med J, 2010, 31(4):374-81.
    [8] Yee DS, Narula N, Ramzy I, et al. Reduced annexin II protein expression in high-grade prostatic intraepithelial neoplasia and prostate cancer[J]. Arch Pathol Lab Med, 2007, 131(6):902-8.
    [9] Stewart J, Fleshner N, Cole H, et al. Comparison of annexin II, p63 and alpha-methylacyl-CoA racemase immunoreactivity in prostatic tissue: a tissue microarray study[J]. J Clin Pathol, 2007, 60 (7):773-80.
    [10] Bao H, Jiang M, Zhu M, et al. Overexpression of annexin II affects the proliferation, apoptosis, invasion and production of proangiogenic factors in multiple myeloma[J]. Int J Hematol, 20 09, 90(2):177-85.
    [11] Díaz VM, Hurtado M, Thomson TM, et al. Specific interaction of tissue-type plasminogen activator (t-PA) with annexin II on the membrane of pancreatic cancer cells activates plasminogen and promotes invasion in vitro[J]. Gut, 2004, 53(7):993-1000.
    [12] Falsey RR, Marron MT, Gunaherath GM, et al. Actin microfilament aggregation induced by withaferin A is mediated by annexin II[J]. Nat Chem Biol, 2006, 2(1):33-8.
    [13] Kirshner J, Schumann D, Shively JE. CEACAM1, a cell-cell adhesion molecule, directly associates with annexin II in a threedimensional model of mammary morphogenesis[J]. J Biol Chem, 20 03, 278(50):50338-45.
    [14] Kugler A, Hemmerlein B,Thelen P, et al. Expression of metalloproteinase-2 and 9 and their inhibitors in renal cell carcinoma[J]. J Urol, 1998, 160(5): 1914-8.
计量
  • 文章访问数:  1248
  • HTML全文浏览量:  363
  • PDF下载量:  561
  • 被引次数: 0
出版历程
  • 刊出日期:  2014-07-24

目录

    /

    返回文章
    返回
    x 关闭 永久关闭